OUR SERVICES
MIMIC MED provides pharmaceutical and healthcare companies who want to enter China or who are already operating in China, with relevant insights regarding regulation, commercialization, financing and physician/patient behaviour. Our insights are aimed at effectively designing and implementing strategies around market entry, market expansion, commercialization, price optimization and distribution.
We cover a spectrum of processes including pharmaceutical finish dosage forms, APIs, biotechnology products, functional foods as well as veterinary products, medical devices and medical equipment.
x
Market opportunity evaluation
Entry and growth strategy
Implementation
Additional services
While we have worked with clients across a broad spectrum of healthcare categories, we have also developed particular expertise in the following categories:
Healthcare in China is one of the biggest and fastest growing markets in the world, driven largely by growth in government expenditures and increasing purchasing powers of consumers for private healthcare consumption.
READ NOW
MENU
CHINA
MIMIC GROUP CHINA
Room 1112, Block A WOLICITY
No. 31 Lane 2419 Hunan Road
Pudong New District, Shanghai
201204, China
HONG KONG
MIMIC GROUP HONG KONG
Room 815, 8/F Star House,
3 Salisbury Road,
Tsim Sha Tsui, Kowloon,
Hong Kong
POLAND
MIMIC GROUP POLAND
ul. Gimnazjalna 2A
85-007 Bydgoszcz
Polska
SPAIN
MIMIC GROUP SPAIN
Gabriel Garcia Marquez 4,
Las Rozas, 28232
Madrid, Spain
UNITED STATES
MIMIC GROUP US
20 E Thomas Rd, suite 2200,
Phoenix, AZ 85012,
USA
©MIMIC MED I PRODUCED BY BEHMEH MEDIA